Prophylaxis with abemaciclib delays tumorigenesis in dMMR mice by altering immune responses and reducing immunosuppressive extracellular vesicle secretion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prophylaxis with abemaciclib delays tumorigenesis in dMMR mice by altering immune responses and reducing immunosuppressive extracellular vesicle secretion

Published:2024-09 Issue: Volume:47 Page:102053
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Wolff Annabell,Krone Paula,Maennicke Johanna,Henne Julia,Oehmcke-Hecht Sonja,Redwanz Caterina^ORCID,Bergmann-Ewert Wendy^ORCID,Junghanss Christian,Henze Larissa^ORCID,Maletzki Claudia^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Reference61 articles.

1. Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer;Corona;Drug Des Devel Ther,2018

2. MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer;Goetz;J Clin Oncol,2017

3. Riess C, Irmscher N, Salewski I, et al Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology? 40 (2020) 153–171. doi:10.1007/s10555-020-09940-4.

4. The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer;Ding;Int. J. Mol. Sci.,2020

5. Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation;Bonelli;Biochem. Pharmacol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP